Global Biosimilars/Follow-on-Biologics Market Professional Survey Report 2021

Report Description


The Global Biosimilars/Follow-on-Biologics Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Biosimilars/Follow-on-Biologics Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Biosimilars/Follow-on-Biologics Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Biosimilars/Follow-on-Biologics Market product affairs. The report is at risk of project regarding this Biosimilars/Follow-on-Biologics Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Novartis
  • Synthon Pharmaceuticals
  • Teva Pharmaceutical Industries
  • LG Life Sciences
  • Celltrion
  • Biocon
  • Hospira
  • Merck Group
  • Biogen idec Inc.
  • Genentech (Roche Group)

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Biosimilars/Follow-on-Biologics related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Biosimilars/Follow-on-Biologics Market

Biosimilars/Follow-on-Biologics Market

Report Highlights:


The Biosimilars/Follow-on-Biologics Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Biosimilars/Follow-on-Biologics Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Biosimilars/Follow-on-Biologics Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Biosimilars/Follow-on-Biologics Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Biosimilars/Follow-on-Biologics marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Biosimilars/Follow-on-Biologics market using a bottom-up approach, wherein manufacturers value data for different type (Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Peptide and Others), of Biosimilars/Follow-on-Biologics market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Biosimilars/Follow-on-Biologics Market

Biosimilars/Follow-on-Biologics Market

Key Target Audience:


  • Biosimilars/Follow-on-Biologics market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Biosimilars/Follow-on-Biologics market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Biosimilars/Follow-on-Biologics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Biosimilars/Follow-on-Biologics market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Human growth hormone
  • Erythropoietin
  • Monoclonal antibodies
  • Insulin
  • Interferon
  • Granulocyte-Colony Stimulating Factor
  • Peptide and Others

By end-user also classify into, the Global Biosimilars/Follow-on-Biologics market:


Global Biosimilars/Follow-on-Biologics market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Blood disorders
  • Oncology diseases
  • Chronic and autoimmune diseases
  • Growth hormone deficiencies and Others

Highlights of this 2021-2027 Biosimilars/Follow-on-Biologics Market Report:

  • Market dynamics, Biosimilars/Follow-on-Biologics economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Biosimilars/Follow-on-Biologics industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Biosimilars/Follow-on-Biologics Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Biosimilars/Follow-on-Biologics businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Biosimilars/Follow-on-Biologics market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com

Table of Contents

Executive Summary
1 Industry Overview of Biosimilars/Follow-on-Biologics
1.1 Definition of Biosimilars/Follow-on-Biologics
1.2 Biosimilars/Follow-on-Biologics Segment by Type
1.2.1 Global Biosimilars/Follow-on-Biologics Production Growth Rate Comparison by Types (2016-2027)
1.2.2 Human growth hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.2.8 Peptide
1.2.9 Others
1.3 Biosimilars/Follow-on-Biologics Segment by Applications
1.3.1 Global Biosimilars/Follow-on-Biologics Consumption Comparison by Applications (2016-2027)
1.3.2 Blood disorders
1.3.3 Oncology diseases
1.3.4 Chronic and autoimmune diseases
1.3.5 Growth hormone deficiencies
1.3.6 Others
1.4 Global Biosimilars/Follow-on-Biologics Overall Market
1.4.1 Global Biosimilars/Follow-on-Biologics Revenue (2016-2027)
1.4.2 Global Biosimilars/Follow-on-Biologics Production (2016-2027)
1.4.3 North America Biosimilars/Follow-on-Biologics Status and Prospect (2016-2027)
1.4.4 Europe Biosimilars/Follow-on-Biologics Status and Prospect (2016-2027)
1.4.5 China Biosimilars/Follow-on-Biologics Status and Prospect (2016-2027)
1.4.6 Japan Biosimilars/Follow-on-Biologics Status and Prospect (2016-2027)
1.4.7 Southeast Asia Biosimilars/Follow-on-Biologics Status and Prospect (2016-2027)
1.4.8 India Biosimilars/Follow-on-Biologics Status and Prospect (2016-2027)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biosimilars/Follow-on-Biologics
2.3 Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
2.4 Industry Chain Structure of Biosimilars/Follow-on-Biologics

3 Development and Manufacturing Plants Analysis of Biosimilars/Follow-on-Biologics
3.1 Capacity and Commercial Production Date
3.2 Global Biosimilars/Follow-on-Biologics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Biosimilars/Follow-on-Biologics
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Biosimilars/Follow-on-Biologics Production and Capacity Analysis
4.2 Biosimilars/Follow-on-Biologics Revenue Analysis
4.3 Biosimilars/Follow-on-Biologics Price Analysis
4.4 Market Concentration Degree

5 Biosimilars/Follow-on-Biologics Regional Market Analysis
5.1 Biosimilars/Follow-on-Biologics Production by Regions
5.1.1 Global Biosimilars/Follow-on-Biologics Production by Regions
5.1.2 Global Biosimilars/Follow-on-Biologics Revenue by Regions
5.2 Biosimilars/Follow-on-Biologics Consumption by Regions
5.3 North America Biosimilars/Follow-on-Biologics Market Analysis
5.3.1 North America Biosimilars/Follow-on-Biologics Production
5.3.2 North America Biosimilars/Follow-on-Biologics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Biosimilars/Follow-on-Biologics Import and Export
5.4 Europe Biosimilars/Follow-on-Biologics Market Analysis
5.4.1 Europe Biosimilars/Follow-on-Biologics Production
5.4.2 Europe Biosimilars/Follow-on-Biologics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Biosimilars/Follow-on-Biologics Import and Export
5.5 China Biosimilars/Follow-on-Biologics Market Analysis
5.5.1 China Biosimilars/Follow-on-Biologics Production
5.5.2 China Biosimilars/Follow-on-Biologics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Biosimilars/Follow-on-Biologics Import and Export
5.6 Japan Biosimilars/Follow-on-Biologics Market Analysis
5.6.1 Japan Biosimilars/Follow-on-Biologics Production
5.6.2 Japan Biosimilars/Follow-on-Biologics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Biosimilars/Follow-on-Biologics Import and Export
5.7 Southeast Asia Biosimilars/Follow-on-Biologics Market Analysis
5.7.1 Southeast Asia Biosimilars/Follow-on-Biologics Production
5.7.2 Southeast Asia Biosimilars/Follow-on-Biologics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Biosimilars/Follow-on-Biologics Import and Export
5.8 India Biosimilars/Follow-on-Biologics Market Analysis
5.8.1 India Biosimilars/Follow-on-Biologics Production
5.8.2 India Biosimilars/Follow-on-Biologics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Biosimilars/Follow-on-Biologics Import and Export

6 Biosimilars/Follow-on-Biologics Segment Market Analysis (by Type)
6.1 Global Biosimilars/Follow-on-Biologics Production by Type
6.2 Global Biosimilars/Follow-on-Biologics Revenue by Type
6.3 Biosimilars/Follow-on-Biologics Price by Type

7 Biosimilars/Follow-on-Biologics Segment Market Analysis (by Application)
7.1 Global Biosimilars/Follow-on-Biologics Consumption by Application
7.2 Global Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2016-2021)

8 Biosimilars/Follow-on-Biologics Major Manufacturers Analysis
8.1 Novartis
8.1.1 Novartis Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.1.2 Novartis Product Introduction, Application and Specification
8.1.3 Novartis Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.1.4 Main Business and Markets Served
8.2 Synthon Pharmaceuticals
8.2.1 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.2.2 Synthon Pharmaceuticals Product Introduction, Application and Specification
8.2.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.2.4 Main Business and Markets Served
8.3 Teva Pharmaceutical Industries
8.3.1 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.3.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
8.3.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.3.4 Main Business and Markets Served
8.4 LG Life Sciences
8.4.1 LG Life Sciences Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.4.2 LG Life Sciences Product Introduction, Application and Specification
8.4.3 LG Life Sciences Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.4.4 Main Business and Markets Served
8.5 Celltrion
8.5.1 Celltrion Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.5.2 Celltrion Product Introduction, Application and Specification
8.5.3 Celltrion Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.5.4 Main Business and Markets Served
8.6 Biocon
8.6.1 Biocon Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.6.2 Biocon Product Introduction, Application and Specification
8.6.3 Biocon Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.6.4 Main Business and Markets Served
8.7 Hospira
8.7.1 Hospira Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.7.2 Hospira Product Introduction, Application and Specification
8.7.3 Hospira Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.7.4 Main Business and Markets Served
8.8 Merck Group
8.8.1 Merck Group Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.8.2 Merck Group Product Introduction, Application and Specification
8.8.3 Merck Group Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.8.4 Main Business and Markets Served
8.9 Biogen idec, Inc.
8.9.1 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.9.2 Biogen idec, Inc. Product Introduction, Application and Specification
8.9.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.9.4 Main Business and Markets Served
8.10 Genentech (Roche Group)
8.10.1 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.10.2 Genentech (Roche Group) Product Introduction, Application and Specification
8.10.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Biosimilars/Follow-on-Biologics Market
9.1 Global Biosimilars/Follow-on-Biologics Market Trend Analysis
9.1.1 Global Biosimilars/Follow-on-Biologics Market Size (Volume and Value) Forecast 2021-2027
9.2 Biosimilars/Follow-on-Biologics Regional Market Trend
9.2.1 North America Biosimilars/Follow-on-Biologics Forecast 2021-2027
9.2.2 Europe Biosimilars/Follow-on-Biologics Forecast 2021-2027
9.2.3 China Biosimilars/Follow-on-Biologics Forecast 2021-2027
9.2.4 Japan Biosimilars/Follow-on-Biologics Forecast 2021-2027
9.2.5 Southeast Asia Biosimilars/Follow-on-Biologics Forecast 2021-2027
9.2.6 India Biosimilars/Follow-on-Biologics Forecast 2021-2027
9.3 Biosimilars/Follow-on-Biologics Market Trend (Product Type)
9.4 Biosimilars/Follow-on-Biologics Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Biosimilars/Follow-on-Biologics Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Biosimilars/Follow-on-Biologics
Table Global Biosimilars/Follow-on-Biologics Production (K Pcs) Growth Rate Comparison by Types (2016-2027)
Figure Global Biosimilars/Follow-on-Biologics Production Market Share by Types in 2020
Figure Human growth hormone Product Picture
Figure Erythropoietin Product Picture
Figure Monoclonal antibodies Product Picture
Figure Insulin Product Picture
Figure Interferon Product Picture
Figure Granulocyte-Colony Stimulating Factor Product Picture
Figure Peptide Product Picture
Figure Others Product Picture
Table Global Biosimilars/Follow-on-Biologics Consumption (K Pcs) Comparison by Applications (2016-2027)
Figure Global Biosimilars/Follow-on-Biologics Consumption Market Share by Applications in 2020
Figure Blood disorders
Figure Oncology diseases
Figure Chronic and autoimmune diseases
Figure Growth hormone deficiencies
Figure Others
Figure Global Biosimilars/Follow-on-Biologics Revenue (Million USD) (2016-2027)
Figure Global Biosimilars/Follow-on-Biologics Production (K Pcs) (2016-2027)
Figure North America Biosimilars/Follow-on-Biologics Market Size (Million USD) (2016-2027)
Figure Europe Biosimilars/Follow-on-Biologics Market Size (Million USD) (2016-2027)
Figure China Biosimilars/Follow-on-Biologics Market Size (Million USD) (2016-2027)
Figure Japan Biosimilars/Follow-on-Biologics Market Size (Million USD) (2016-2027)
Figure Southeast Asia Biosimilars/Follow-on-Biologics Market Size (Million USD) (2016-2027)
Figure India Biosimilars/Follow-on-Biologics Market Size (Million USD) (2016-2027)
Table Biosimilars/Follow-on-Biologics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Biosimilars/Follow-on-Biologics in 2020
Figure Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
Figure Industry Chain Structure of Biosimilars/Follow-on-Biologics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Biosimilars/Follow-on-Biologics Manufacturing Plants Distribution
Table Biosimilars/Follow-on-Biologics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Biosimilars/Follow-on-Biologics Capacity (K Pcs) of Major Manufacturers (2016-2021)
Table Biosimilars/Follow-on-Biologics Production (K Pcs) of Major Manufacturers (2016-2021)
Table Biosimilars/Follow-on-Biologics Production Market Share of Major Manufacturers (2016-2021)
Figure Biosimilars/Follow-on-Biologics Production Share by Manufacturers in 2020
Table Biosimilars/Follow-on-Biologics Revenue (Million US$) of Major Manufacturers (2016-2021)
Table Biosimilars/Follow-on-Biologics Revenue Market Share of Major Manufacturers (2016-2021)
Figure Biosimilars/Follow-on-Biologics Revenue Share by Manufacturers in 2020
Table Biosimilars/Follow-on-Biologics Average Price (USD/Pcs) of Major Manufacturers (2016-2021)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Biosimilars/Follow-on-Biologics Production by Regions 2016-2021 (K Pcs)
Table Global Biosimilars/Follow-on-Biologics Production Market Share by Regions 2016-2021
Figure Global Biosimilars/Follow-on-Biologics Production Market Share by Regions in 2020
Table Global Biosimilars/Follow-on-Biologics Revenue by Regions 2016-2021 (Million USD)
Table Global Biosimilars/Follow-on-Biologics Revenue Market Share by Regions 2016-2021
Figure Global Biosimilars/Follow-on-Biologics Revenue Market Share by Regions in 2020
Table Global Biosimilars/Follow-on-Biologics Consumption by Regions 2016-2021 (K Pcs)
Table Global Biosimilars/Follow-on-Biologics Consumption Market Share by Regions 2016-2021
Figure North America Biosimilars/Follow-on-Biologics Production Growth Rate 2016-2021 (K Pcs)
Figure North America Biosimilars/Follow-on-Biologics Revenue Growth Rate 2016-2021 (Million USD)
Table North America Biosimilars/Follow-on-Biologics Production, Consumption Import and Export (K Pcs)
Figure Europe Biosimilars/Follow-on-Biologics Production Growth Rate 2016-2021 (K Pcs)
Figure Europe Biosimilars/Follow-on-Biologics Revenue Growth Rate 2016-2021 (Million USD)
Table Europe Biosimilars/Follow-on-Biologics Production, Consumption Import and Export (K Pcs)
Figure China Biosimilars/Follow-on-Biologics Production Growth Rate 2016-2021 (K Pcs)
Figure China Biosimilars/Follow-on-Biologics Revenue Growth Rate 2016-2021 (Million USD)
Table China Biosimilars/Follow-on-Biologics Production, Consumption Import and Export (K Pcs)
Figure Japan Biosimilars/Follow-on-Biologics Production Growth Rate 2016-2021 (K Pcs)
Figure Japan Biosimilars/Follow-on-Biologics Revenue Growth Rate 2016-2021 (Million USD)
Table Japan Biosimilars/Follow-on-Biologics Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Biosimilars/Follow-on-Biologics Production Growth Rate 2016-2021 (K Pcs)
Figure Southeast Asia Biosimilars/Follow-on-Biologics Revenue Growth Rate 2016-2021 (Million USD)
Table Southeast Asia Biosimilars/Follow-on-Biologics Production, Consumption Import and Export (K Pcs)
Figure India Biosimilars/Follow-on-Biologics Production Growth Rate 2016-2021 (K Pcs)
Figure India Biosimilars/Follow-on-Biologics Revenue Growth Rate 2016-2021 (Million USD)
Table India Biosimilars/Follow-on-Biologics Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Biosimilars/Follow-on-Biologics Market Share by Application (2016-2021)
Figure Global Value (Consumption) Biosimilars/Follow-on-Biologics Market Share by Application (2016-2021)
Table Novartis Biosimilars/Follow-on-Biologics Production Sites and Area Served
Table Novartis Biosimilars/Follow-on-Biologics Product Introduction, Application and Specification
Table Novartis Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2016-2021)
Table Novartis Biosimilars/Follow-on-Biologics Production Growth Rate (2016-2021)
Table Novartis Biosimilars/Follow-on-Biologics Production Market Share (2016-2021)
Figure Novartis Biosimilars/Follow-on-Biologics Revenue Market Share (2016-2021)
Table Novartis Biosimilars/Follow-on-Biologics Main Business and Markets Served
Table Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production Sites and Area Served
Table Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Introduction, Application and Specification
Table Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2016-2021)
Table Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production Growth Rate (2016-2021)
Table Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production Market Share (2016-2021)
Figure Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Revenue Market Share (2016-2021)
Table Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Main Business and Markets Served
Table Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production Sites and Area Served
Table Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Introduction, Application and Specification
Table Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2016-2021)
Table Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production Growth Rate (2016-2021)
Table Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production Market Share (2016-2021)
Figure Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Revenue Market Share (2016-2021)
Table Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Main Business and Markets Served
Table LG Life Sciences Biosimilars/Follow-on-Biologics Production Sites and Area Served
Table LG Life Sciences Biosimilars/Follow-on-Biologics Product Introduction, Application and Specification
Table LG Life Sciences Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2016-2021)
Table LG Life Sciences Biosimilars/Follow-on-Biologics Production Growth Rate (2016-2021)
Table LG Life Sciences Biosimilars/Follow-on-Biologics Production Market Share (2016-2021)
Figure LG Life Sciences Biosimilars/Follow-on-Biologics Revenue Market Share (2016-2021)
Table LG Life Sciences Biosimilars/Follow-on-Biologics Main Business and Markets Served
Table Celltrion Biosimilars/Follow-on-Biologics Production Sites and Area Served
Table Celltrion Biosimilars/Follow-on-Biologics Product Introduction, Application and Specification
Table Celltrion Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2016-2021)
Table Celltrion Biosimilars/Follow-on-Biologics Production Growth Rate (2016-2021)
Table Celltrion Biosimilars/Follow-on-Biologics Production Market Share (2016-2021)
Figure Celltrion Biosimilars/Follow-on-Biologics Re

Biosimilars/Follow-on-Biologics Market Segments


Biosimilars/Follow-on-Biologics Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Human growth hormone
  • Erythropoietin
  • Monoclonal antibodies
  • Insulin
  • Interferon
  • Granulocyte-Colony Stimulating Factor
  • Peptide and Others

Biosimilars/Follow-on-Biologics Application Outlook (Revenue, USD Million, 2021 2027)


  • Blood disorders
  • Oncology diseases
  • Chronic and autoimmune diseases
  • Growth hormone deficiencies and Others

Biosimilars/Follow-on-Biologics Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Biosimilars/Follow-on-Biologics market, By Product Type Outlook
      • Human growth hormone
      • Erythropoietin
      • Monoclonal antibodies
      • Insulin
      • Interferon
      • Granulocyte-Colony Stimulating Factor
      • Peptide and Others

    • Biosimilars/Follow-on-Biologics market, By Application Outlook
      • Blood disorders
      • Oncology diseases
      • Chronic and autoimmune diseases
      • Growth hormone deficiencies and Others

  • Europe
    • Biosimilars/Follow-on-Biologics market, By Product Type Outlook
      • Human growth hormone
      • Erythropoietin
      • Monoclonal antibodies
      • Insulin
      • Interferon
      • Granulocyte-Colony Stimulating Factor
      • Peptide and Others

    • Biosimilars/Follow-on-Biologics market, By Application Outlook
      • Blood disorders
      • Oncology diseases
      • Chronic and autoimmune diseases
      • Growth hormone deficiencies and Others

  • Asia Pacific
    • Biosimilars/Follow-on-Biologics market, By Product Type Outlook
      • Human growth hormone
      • Erythropoietin
      • Monoclonal antibodies
      • Insulin
      • Interferon
      • Granulocyte-Colony Stimulating Factor
      • Peptide and Others

    • Biosimilars/Follow-on-Biologics market, By Application Outlook
      • Blood disorders
      • Oncology diseases
      • Chronic and autoimmune diseases
      • Growth hormone deficiencies and Others

  • Latin America
    • Biosimilars/Follow-on-Biologics market, By Product Type Outlook
      • Human growth hormone
      • Erythropoietin
      • Monoclonal antibodies
      • Insulin
      • Interferon
      • Granulocyte-Colony Stimulating Factor
      • Peptide and Others

    • Biosimilars/Follow-on-Biologics market, By Application Outlook
      • Blood disorders
      • Oncology diseases
      • Chronic and autoimmune diseases
      • Growth hormone deficiencies and Others

  • Middle East & Africa
    • Biosimilars/Follow-on-Biologics market, By Product Type Outlook
      • Human growth hormone
      • Erythropoietin
      • Monoclonal antibodies
      • Insulin
      • Interferon
      • Granulocyte-Colony Stimulating Factor
      • Peptide and Others

    • Biosimilars/Follow-on-Biologics market, By Application Outlook
      • Blood disorders
      • Oncology diseases
      • Chronic and autoimmune diseases
      • Growth hormone deficiencies and Others

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

Report Description


The Global Biosimilars/Follow-on-Biologics Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Biosimilars/Follow-on-Biologics Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Biosimilars/Follow-on-Biologics Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Biosimilars/Follow-on-Biologics Market product affairs. The report is at risk of project regarding this Biosimilars/Follow-on-Biologics Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Novartis
  • Synthon Pharmaceuticals
  • Teva Pharmaceutical Industries
  • LG Life Sciences
  • Celltrion
  • Biocon
  • Hospira
  • Merck Group
  • Biogen idec Inc.
  • Genentech (Roche Group)

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Biosimilars/Follow-on-Biologics related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Biosimilars/Follow-on-Biologics Market

Biosimilars/Follow-on-Biologics Market

Report Highlights:


The Biosimilars/Follow-on-Biologics Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Biosimilars/Follow-on-Biologics Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Biosimilars/Follow-on-Biologics Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Biosimilars/Follow-on-Biologics Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Biosimilars/Follow-on-Biologics marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Biosimilars/Follow-on-Biologics market using a bottom-up approach, wherein manufacturers value data for different type (Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Peptide and Others), of Biosimilars/Follow-on-Biologics market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Biosimilars/Follow-on-Biologics Market

Biosimilars/Follow-on-Biologics Market

Key Target Audience:


  • Biosimilars/Follow-on-Biologics market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Biosimilars/Follow-on-Biologics market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Biosimilars/Follow-on-Biologics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Biosimilars/Follow-on-Biologics market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Human growth hormone
  • Erythropoietin
  • Monoclonal antibodies
  • Insulin
  • Interferon
  • Granulocyte-Colony Stimulating Factor
  • Peptide and Others

By end-user also classify into, the Global Biosimilars/Follow-on-Biologics market:


Global Biosimilars/Follow-on-Biologics market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Blood disorders
  • Oncology diseases
  • Chronic and autoimmune diseases
  • Growth hormone deficiencies and Others

Highlights of this 2021-2027 Biosimilars/Follow-on-Biologics Market Report:

  • Market dynamics, Biosimilars/Follow-on-Biologics economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Biosimilars/Follow-on-Biologics industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Biosimilars/Follow-on-Biologics Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Biosimilars/Follow-on-Biologics businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Biosimilars/Follow-on-Biologics market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com
Table of Contents

Executive Summary
1 Industry Overview of Biosimilars/Follow-on-Biologics
1.1 Definition of Biosimilars/Follow-on-Biologics
1.2 Biosimilars/Follow-on-Biologics Segment by Type
1.2.1 Global Biosimilars/Follow-on-Biologics Production Growth Rate Comparison by Types (2016-2027)
1.2.2 Human growth hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.2.8 Peptide
1.2.9 Others
1.3 Biosimilars/Follow-on-Biologics Segment by Applications
1.3.1 Global Biosimilars/Follow-on-Biologics Consumption Comparison by Applications (2016-2027)
1.3.2 Blood disorders
1.3.3 Oncology diseases
1.3.4 Chronic and autoimmune diseases
1.3.5 Growth hormone deficiencies
1.3.6 Others
1.4 Global Biosimilars/Follow-on-Biologics Overall Market
1.4.1 Global Biosimilars/Follow-on-Biologics Revenue (2016-2027)
1.4.2 Global Biosimilars/Follow-on-Biologics Production (2016-2027)
1.4.3 North America Biosimilars/Follow-on-Biologics Status and Prospect (2016-2027)
1.4.4 Europe Biosimilars/Follow-on-Biologics Status and Prospect (2016-2027)
1.4.5 China Biosimilars/Follow-on-Biologics Status and Prospect (2016-2027)
1.4.6 Japan Biosimilars/Follow-on-Biologics Status and Prospect (2016-2027)
1.4.7 Southeast Asia Biosimilars/Follow-on-Biologics Status and Prospect (2016-2027)
1.4.8 India Biosimilars/Follow-on-Biologics Status and Prospect (2016-2027)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biosimilars/Follow-on-Biologics
2.3 Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
2.4 Industry Chain Structure of Biosimilars/Follow-on-Biologics

3 Development and Manufacturing Plants Analysis of Biosimilars/Follow-on-Biologics
3.1 Capacity and Commercial Production Date
3.2 Global Biosimilars/Follow-on-Biologics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Biosimilars/Follow-on-Biologics
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Biosimilars/Follow-on-Biologics Production and Capacity Analysis
4.2 Biosimilars/Follow-on-Biologics Revenue Analysis
4.3 Biosimilars/Follow-on-Biologics Price Analysis
4.4 Market Concentration Degree

5 Biosimilars/Follow-on-Biologics Regional Market Analysis
5.1 Biosimilars/Follow-on-Biologics Production by Regions
5.1.1 Global Biosimilars/Follow-on-Biologics Production by Regions
5.1.2 Global Biosimilars/Follow-on-Biologics Revenue by Regions
5.2 Biosimilars/Follow-on-Biologics Consumption by Regions
5.3 North America Biosimilars/Follow-on-Biologics Market Analysis
5.3.1 North America Biosimilars/Follow-on-Biologics Production
5.3.2 North America Biosimilars/Follow-on-Biologics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Biosimilars/Follow-on-Biologics Import and Export
5.4 Europe Biosimilars/Follow-on-Biologics Market Analysis
5.4.1 Europe Biosimilars/Follow-on-Biologics Production
5.4.2 Europe Biosimilars/Follow-on-Biologics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Biosimilars/Follow-on-Biologics Import and Export
5.5 China Biosimilars/Follow-on-Biologics Market Analysis
5.5.1 China Biosimilars/Follow-on-Biologics Production
5.5.2 China Biosimilars/Follow-on-Biologics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Biosimilars/Follow-on-Biologics Import and Export
5.6 Japan Biosimilars/Follow-on-Biologics Market Analysis
5.6.1 Japan Biosimilars/Follow-on-Biologics Production
5.6.2 Japan Biosimilars/Follow-on-Biologics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Biosimilars/Follow-on-Biologics Import and Export
5.7 Southeast Asia Biosimilars/Follow-on-Biologics Market Analysis
5.7.1 Southeast Asia Biosimilars/Follow-on-Biologics Production
5.7.2 Southeast Asia Biosimilars/Follow-on-Biologics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Biosimilars/Follow-on-Biologics Import and Export
5.8 India Biosimilars/Follow-on-Biologics Market Analysis
5.8.1 India Biosimilars/Follow-on-Biologics Production
5.8.2 India Biosimilars/Follow-on-Biologics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Biosimilars/Follow-on-Biologics Import and Export

6 Biosimilars/Follow-on-Biologics Segment Market Analysis (by Type)
6.1 Global Biosimilars/Follow-on-Biologics Production by Type
6.2 Global Biosimilars/Follow-on-Biologics Revenue by Type
6.3 Biosimilars/Follow-on-Biologics Price by Type

7 Biosimilars/Follow-on-Biologics Segment Market Analysis (by Application)
7.1 Global Biosimilars/Follow-on-Biologics Consumption by Application
7.2 Global Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2016-2021)

8 Biosimilars/Follow-on-Biologics Major Manufacturers Analysis
8.1 Novartis
8.1.1 Novartis Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.1.2 Novartis Product Introduction, Application and Specification
8.1.3 Novartis Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.1.4 Main Business and Markets Served
8.2 Synthon Pharmaceuticals
8.2.1 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.2.2 Synthon Pharmaceuticals Product Introduction, Application and Specification
8.2.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.2.4 Main Business and Markets Served
8.3 Teva Pharmaceutical Industries
8.3.1 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.3.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
8.3.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.3.4 Main Business and Markets Served
8.4 LG Life Sciences
8.4.1 LG Life Sciences Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.4.2 LG Life Sciences Product Introduction, Application and Specification
8.4.3 LG Life Sciences Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.4.4 Main Business and Markets Served
8.5 Celltrion
8.5.1 Celltrion Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.5.2 Celltrion Product Introduction, Application and Specification
8.5.3 Celltrion Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.5.4 Main Business and Markets Served
8.6 Biocon
8.6.1 Biocon Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.6.2 Biocon Product Introduction, Application and Specification
8.6.3 Biocon Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.6.4 Main Business and Markets Served
8.7 Hospira
8.7.1 Hospira Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.7.2 Hospira Product Introduction, Application and Specification
8.7.3 Hospira Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.7.4 Main Business and Markets Served
8.8 Merck Group
8.8.1 Merck Group Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.8.2 Merck Group Product Introduction, Application and Specification
8.8.3 Merck Group Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.8.4 Main Business and Markets Served
8.9 Biogen idec, Inc.
8.9.1 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.9.2 Biogen idec, Inc. Product Introduction, Application and Specification
8.9.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.9.4 Main Business and Markets Served
8.10 Genentech (Roche Group)
8.10.1 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Production Sites and Area Served
8.10.2 Genentech (Roche Group) Product Introduction, Application and Specification
8.10.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Biosimilars/Follow-on-Biologics Market
9.1 Global Biosimilars/Follow-on-Biologics Market Trend Analysis
9.1.1 Global Biosimilars/Follow-on-Biologics Market Size (Volume and Value) Forecast 2021-2027
9.2 Biosimilars/Follow-on-Biologics Regional Market Trend
9.2.1 North America Biosimilars/Follow-on-Biologics Forecast 2021-2027
9.2.2 Europe Biosimilars/Follow-on-Biologics Forecast 2021-2027
9.2.3 China Biosimilars/Follow-on-Biologics Forecast 2021-2027
9.2.4 Japan Biosimilars/Follow-on-Biologics Forecast 2021-2027
9.2.5 Southeast Asia Biosimilars/Follow-on-Biologics Forecast 2021-2027
9.2.6 India Biosimilars/Follow-on-Biologics Forecast 2021-2027
9.3 Biosimilars/Follow-on-Biologics Market Trend (Product Type)
9.4 Biosimilars/Follow-on-Biologics Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Biosimilars/Follow-on-Biologics Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

Biosimilars/Follow-on-Biologics Market Segments


Biosimilars/Follow-on-Biologics Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Human growth hormone
  • Erythropoietin
  • Monoclonal antibodies
  • Insulin
  • Interferon
  • Granulocyte-Colony Stimulating Factor
  • Peptide and Others

Biosimilars/Follow-on-Biologics Application Outlook (Revenue, USD Million, 2021 2027)


  • Blood disorders
  • Oncology diseases
  • Chronic and autoimmune diseases
  • Growth hormone deficiencies and Others

Biosimilars/Follow-on-Biologics Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Biosimilars/Follow-on-Biologics market, By Product Type Outlook
      • Human growth hormone
      • Erythropoietin
      • Monoclonal antibodies
      • Insulin
      • Interferon
      • Granulocyte-Colony Stimulating Factor
      • Peptide and Others

    • Biosimilars/Follow-on-Biologics market, By Application Outlook
      • Blood disorders
      • Oncology diseases
      • Chronic and autoimmune diseases
      • Growth hormone deficiencies and Others

  • Europe
    • Biosimilars/Follow-on-Biologics market, By Product Type Outlook
      • Human growth hormone
      • Erythropoietin
      • Monoclonal antibodies
      • Insulin
      • Interferon
      • Granulocyte-Colony Stimulating Factor
      • Peptide and Others

    • Biosimilars/Follow-on-Biologics market, By Application Outlook
      • Blood disorders
      • Oncology diseases
      • Chronic and autoimmune diseases
      • Growth hormone deficiencies and Others

  • Asia Pacific
    • Biosimilars/Follow-on-Biologics market, By Product Type Outlook
      • Human growth hormone
      • Erythropoietin
      • Monoclonal antibodies
      • Insulin
      • Interferon
      • Granulocyte-Colony Stimulating Factor
      • Peptide and Others

    • Biosimilars/Follow-on-Biologics market, By Application Outlook
      • Blood disorders
      • Oncology diseases
      • Chronic and autoimmune diseases
      • Growth hormone deficiencies and Others

  • Latin America
    • Biosimilars/Follow-on-Biologics market, By Product Type Outlook
      • Human growth hormone
      • Erythropoietin
      • Monoclonal antibodies
      • Insulin
      • Interferon
      • Granulocyte-Colony Stimulating Factor
      • Peptide and Others

    • Biosimilars/Follow-on-Biologics market, By Application Outlook
      • Blood disorders
      • Oncology diseases
      • Chronic and autoimmune diseases
      • Growth hormone deficiencies and Others

  • Middle East & Africa
    • Biosimilars/Follow-on-Biologics market, By Product Type Outlook
      • Human growth hormone
      • Erythropoietin
      • Monoclonal antibodies
      • Insulin
      • Interferon
      • Granulocyte-Colony Stimulating Factor
      • Peptide and Others

    • Biosimilars/Follow-on-Biologics market, By Application Outlook
      • Blood disorders
      • Oncology diseases
      • Chronic and autoimmune diseases
      • Growth hormone deficiencies and Others

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials
List of Tables and Figures
Figure Picture of Biosimilars/Follow-on-Biologics
Table Global Biosimilars/Follow-on-Biologics Production (K Pcs) Growth Rate Comparison by Types (2016-2027)
Figure Global Biosimilars/Follow-on-Biologics Production Market Share by Types in 2020
Figure Human growth hormone Product Picture
Figure Erythropoietin Product Picture
Figure Monoclonal antibodies Product Picture
Figure Insulin Product Picture
Figure Interferon Product Picture
Figure Granulocyte-Colony Stimulating Factor Product Picture
Figure Peptide Product Picture
Figure Others Product Picture
Table Global Biosimilars/Follow-on-Biologics Consumption (K Pcs) Comparison by Applications (2016-2027)
Figure Global Biosimilars/Follow-on-Biologics Consumption Market Share by Applications in 2020
Figure Blood disorders
Figure Oncology diseases
Figure Chronic and autoimmune diseases
Figure Growth hormone deficiencies
Figure Others
Figure Global Biosimilars/Follow-on-Biologics Revenue (Million USD) (2016-2027)
Figure Global Biosimilars/Follow-on-Biologics Production (K Pcs) (2016-2027)
Figure North America Biosimilars/Follow-on-Biologics Market Size (Million USD) (2016-2027)
Figure Europe Biosimilars/Follow-on-Biologics Market Size (Million USD) (2016-2027)
Figure China Biosimilars/Follow-on-Biologics Market Size (Million USD) (2016-2027)
Figure Japan Biosimilars/Follow-on-Biologics Market Size (Million USD) (2016-2027)
Figure Southeast Asia Biosimilars/Follow-on-Biologics Market Size (Million USD) (2016-2027)
Figure India Biosimilars/Follow-on-Biologics Market Size (Million USD) (2016-2027)
Table Biosimilars/Follow-on-Biologics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Biosimilars/Follow-on-Biologics in 2020
Figure Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
Figure Industry Chain Structure of Biosimilars/Follow-on-Biologics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Biosimilars/Follow-on-Biologics Manufacturing Plants Distribution
Table Biosimilars/Follow-on-Biologics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Biosimilars/Follow-on-Biologics Capacity (K Pcs) of Major Manufacturers (2016-2021)
Table Biosimilars/Follow-on-Biologics Production (K Pcs) of Major Manufacturers (2016-2021)
Table Biosimilars/Follow-on-Biologics Production Market Share of Major Manufacturers (2016-2021)
Figure Biosimilars/Follow-on-Biologics Production Share by Manufacturers in 2020
Table Biosimilars/Follow-on-Biologics Revenue (Million US$) of Major Manufacturers (2016-2021)
Table Biosimilars/Follow-on-Biologics Revenue Market Share of Major Manufacturers (2016-2021)
Figure Biosimilars/Follow-on-Biologics Revenue Share by Manufacturers in 2020
Table Biosimilars/Follow-on-Biologics Average Price (USD/Pcs) of Major Manufacturers (2016-2021)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Biosimilars/Follow-on-Biologics Production by Regions 2016-2021 (K Pcs)
Table Global Biosimilars/Follow-on-Biologics Production Market Share by Regions 2016-2021
Figure Global Biosimilars/Follow-on-Biologics Production Market Share by Regions in 2020
Table Global Biosimilars/Follow-on-Biologics Revenue by Regions 2016-2021 (Million USD)
Table Global Biosimilars/Follow-on-Biologics Revenue Market Share by Regions 2016-2021
Figure Global Biosimilars/Follow-on-Biologics Revenue Market Share by Regions in 2020
Table Global Biosimilars/Follow-on-Biologics Consumption by Regions 2016-2021 (K Pcs)
Table Global Biosimilars/Follow-on-Biologics Consumption Market Share by Regions 2016-2021
Figure North America Biosimilars/Follow-on-Biologics Production Growth Rate 2016-2021 (K Pcs)
Figure North America Biosimilars/Follow-on-Biologics Revenue Growth Rate 2016-2021 (Million USD)
Table North America Biosimilars/Follow-on-Biologics Production, Consumption Import and Export (K Pcs)
Figure Europe Biosimilars/Follow-on-Biologics Production Growth Rate 2016-2021 (K Pcs)
Figure Europe Biosimilars/Follow-on-Biologics Revenue Growth Rate 2016-2021 (Million USD)
Table Europe Biosimilars/Follow-on-Biologics Production, Consumption Import and Export (K Pcs)
Figure China Biosimilars/Follow-on-Biologics Production Growth Rate 2016-2021 (K Pcs)
Figure China Biosimilars/Follow-on-Biologics Revenue Growth Rate 2016-2021 (Million USD)
Table China Biosimilars/Follow-on-Biologics Production, Consumption Import and Export (K Pcs)
Figure Japan Biosimilars/Follow-on-Biologics Production Growth Rate 2016-2021 (K Pcs)
Figure Japan Biosimilars/Follow-on-Biologics Revenue Growth Rate 2016-2021 (Million USD)
Table Japan Biosimilars/Follow-on-Biologics Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Biosimilars/Follow-on-Biologics Production Growth Rate 2016-2021 (K Pcs)
Figure Southeast Asia Biosimilars/Follow-on-Biologics Revenue Growth Rate 2016-2021 (Million USD)
Table Southeast Asia Biosimilars/Follow-on-Biologics Production, Consumption Import and Export (K Pcs)
Figure India Biosimilars/Follow-on-Biologics Production Growth Rate 2016-2021 (K Pcs)
Figure India Biosimilars/Follow-on-Biologics Revenue Growth Rate 2016-2021 (Million USD)
Table India Biosimilars/Follow-on-Biologics Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Biosimilars/Follow-on-Biologics Market Share by Application (2016-2021)
Figure Global Value (Consumption) Biosimilars/Follow-on-Biologics Market Share by Application (2016-2021)
Table Novartis Biosimilars/Follow-on-Biologics Production Sites and Area Served
Table Novartis Biosimilars/Follow-on-Biologics Product Introduction, Application and Specification
Table Novartis Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2016-2021)
Table Novartis Biosimilars/Follow-on-Biologics Production Growth Rate (2016-2021)
Table Novartis Biosimilars/Follow-on-Biologics Production Market Share (2016-2021)
Figure Novartis Biosimilars/Follow-on-Biologics Revenue Market Share (2016-2021)
Table Novartis Biosimilars/Follow-on-Biologics Main Business and Markets Served
Table Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production Sites and Area Served
Table Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Introduction, Application and Specification
Table Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2016-2021)
Table Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production Growth Rate (2016-2021)
Table Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production Market Share (2016-2021)
Figure Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Revenue Market Share (2016-2021)
Table Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Main Business and Markets Served
Table Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production Sites and Area Served
Table Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Introduction, Application and Specification
Table Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2016-2021)
Table Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production Growth Rate (2016-2021)
Table Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production Market Share (2016-2021)
Figure Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Revenue Market Share (2016-2021)
Table Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Main Business and Markets Served
Table LG Life Sciences Biosimilars/Follow-on-Biologics Production Sites and Area Served
Table LG Life Sciences Biosimilars/Follow-on-Biologics Product Introduction, Application and Specification
Table LG Life Sciences Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2016-2021)
Table LG Life Sciences Biosimilars/Follow-on-Biologics Production Growth Rate (2016-2021)
Table LG Life Sciences Biosimilars/Follow-on-Biologics Production Market Share (2016-2021)
Figure LG Life Sciences Biosimilars/Follow-on-Biologics Revenue Market Share (2016-2021)
Table LG Life Sciences Biosimilars/Follow-on-Biologics Main Business and Markets Served
Table Celltrion Biosimilars/Follow-on-Biologics Production Sites and Area Served
Table Celltrion Biosimilars/Follow-on-Biologics Product Introduction, Application and Specification
Table Celltrion Biosimilars/Follow-on-Biologics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2016-2021)
Table Celltrion Biosimilars/Follow-on-Biologics Production Growth Rate (2016-2021)
Table Celltrion Biosimilars/Follow-on-Biologics Production Market Share (2016-2021)
Figure Celltrion Biosimilars/Follow-on-Biologics Re
Choose License Type
  • $4250  
  • $6250  
  • $8250  

Secure Payment


img1

Related Reports

Anti-Allergic Drugs Market

Report Description The Global Anti-Allergic Drugs Market Report provides Insightful information to t

Read More

Cannabis Pharmaceutical Market

Key Industry Insights This report is an extensive study that includes a detailed overview of the Can

Read More

Vaccine Packaging Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More